| Miss Cynthia Lansang, PT | |
|
728 N Main St, New Square, NY 10977-8916 | |
| (845) 354-9300 | |
| (845) 517-1924 |
| Full Name | Miss Cynthia Lansang |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 728 N Main St, New Square, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881983286 | NPI | - | NPPES |
| 015460-1 | Other | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 015460-1 (New York) | Primary |
| Provider Name | Refuah Health Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1669470019 PECOS PAC ID: 4880584416 Enrollment ID: O20040317001392 |
News Archive
Children and siblings of those with venous thrombosis, or blood clots in the veins, appear to have more than double the risk of developing the condition than those without a family history, according to a report in the March 23 issue of Archives of Internal Medicine.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
St. Jude Medical, Inc., a global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) of its AnalyST™ implantable cardioverter defibrillator (ICD) with ST Monitoring, a revolutionary device that not only provides life-saving therapy for dangerously fast heart rhythms, but also continuously monitors electrical changes (called ST segments) to help physicians monitor for cardiac problems.
Researchers at Purdue University have created magnetically responsive gold nanostars that may offer a new approach to biomedical imaging. The nanostars gyrate when exposed to a rotating magnetic field and can scatter light to produce a pulsating or "twinkling" effect. This twinkling allows them to stand out more clearly from noisy backgrounds such as those found in biological tissue. Alexander Wei, Ph.D., and Kenneth Ritchie, Ph.D., M.Sc., led the team that created the new gyromagnetic imaging method. The work appears in a paper published in the Journal of the American Chemical Society.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Cynthia Lansang, PT 728 N Main St, New Square, NY 10977-8916 Ph: (845) 354-9300 | Miss Cynthia Lansang, PT 728 N Main St, New Square, NY 10977-8916 Ph: (845) 354-9300 |
News Archive
Children and siblings of those with venous thrombosis, or blood clots in the veins, appear to have more than double the risk of developing the condition than those without a family history, according to a report in the March 23 issue of Archives of Internal Medicine.
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
St. Jude Medical, Inc., a global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) of its AnalyST™ implantable cardioverter defibrillator (ICD) with ST Monitoring, a revolutionary device that not only provides life-saving therapy for dangerously fast heart rhythms, but also continuously monitors electrical changes (called ST segments) to help physicians monitor for cardiac problems.
Researchers at Purdue University have created magnetically responsive gold nanostars that may offer a new approach to biomedical imaging. The nanostars gyrate when exposed to a rotating magnetic field and can scatter light to produce a pulsating or "twinkling" effect. This twinkling allows them to stand out more clearly from noisy backgrounds such as those found in biological tissue. Alexander Wei, Ph.D., and Kenneth Ritchie, Ph.D., M.Sc., led the team that created the new gyromagnetic imaging method. The work appears in a paper published in the Journal of the American Chemical Society.
› Verified 6 days ago